Advertisement
Singapore markets close in 3 hours 41 minutes

  • Straits Times Index

    3,279.70
    -13.43 (-0.41%)
     

  • Nikkei

    37,696.47
    -763.61 (-1.99%)
     

  • Hang Seng

    17,243.20
    +41.93 (+0.24%)
     

  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     

  • Bitcoin USD

    64,172.86
    -2,713.51 (-4.06%)
     

  • CMC Crypto 200

    1,389.61
    -34.49 (-2.42%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • Dow

    38,460.92
    -42.77 (-0.11%)
     

  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     

  • Gold

    2,328.80
    -9.60 (-0.41%)
     

  • Crude Oil

    82.95
    +0.14 (+0.17%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • FTSE Bursa Malaysia

    1,570.29
    -1.19 (-0.08%)
     

  • Jakarta Composite Index

    7,157.23
    -17.30 (-0.24%)
     

  • PSE Index

    6,580.01
    +7.26 (+0.11%)
     

J&J eyeing surgical robotics firm Auris Health: Bloomberg

Reuters
FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake/File Photo (Reuters)

(Reuters) - Johnson & Johnson is pursuing an acquisition of surgical robotics firm Auris Health Inc, Bloomberg reported on Wednesday, citing people with knowledge of the matter.

J&J is seeking to purchase Auris at a premium to the valuation from its latest funding round that valued the company at $2 billion, Bloomberg reported https://bloom.bg/2RG9kwA.

The final deal has not been reached and there is no certainty that the deliberations will lead to a sale of Auris, according to Bloomberg.

J&J declined to comment while Auris could not be immediately reached for comment.

(Reporting by Rishika Chatterjee in Bengaluru; Additional reporting by Mekhla Raina in Bengaluru; Editing by Anil D'Silva)